Constrained Disentanglement (CODE) Network for CT Metal Artifact Reduction in Radiation Therapy

Information

  • Research Project
  • 10184493
  • ApplicationId
    10184493
  • Core Project Number
    R01EB031102
  • Full Project Number
    1R01EB031102-01
  • Serial Number
    031102
  • FOA Number
    PAR-20-155
  • Sub Project Id
  • Project Start Date
    9/15/2021 - 3 years ago
  • Project End Date
    9/14/2024 - 5 months ago
  • Program Officer Name
    SHABESTARI, BEHROUZ
  • Budget Start Date
    9/15/2021 - 3 years ago
  • Budget End Date
    9/14/2024 - 5 months ago
  • Fiscal Year
    2021
  • Support Year
    01
  • Suffix
  • Award Notice Date
    9/14/2021 - 3 years ago

Constrained Disentanglement (CODE) Network for CT Metal Artifact Reduction in Radiation Therapy

? ABSTRACT The World Health Organization reported that cancer is the second leading cause of death globally and is re- sponsible for 9.6 million deaths in 2018. Approximately 50% of all cancer patients receive radiation therapy (RT). Many of them have metal implants, which induce image artifacts in the treatment planning CT images and compromise or preclude treatment in an estimated 15% of all radiation therapy patients. Despite extensive CT metal artifact reduction (MAR) research it remains one of the long-standing challenges in the CT field, without a clinically satisfactory solution. The overall goal of this project is to develop cutting-edge deep learning imaging methods and software solutions for commercial CT scanners to eliminate CT metal artifacts in general and improve RT in particular. We propose a three-pronged approach to systematically tackle this challenge in three specific aims: (1) adversarial learning techniques for estimation of sinogram missing data and metal traces; (2) constrained disentanglement (CODE) networks to remove CT image artifacts during image reconstruction, through post-processing, and in both data and image domains; and (3) systematic evaluation of our proposed CT MAR techniques and clinical translation into robust RT planning methods to maximize the RT treatment planning accuracy and thus improve patient outcomes. Our synergistic track records in CT MAR research, especially with deep imaging methods over the past three years, promises an unprecedented opportunity for a brand-new solution to CT MAR. For the first time we will integrate contemporary AI innovations in data preprocessing, image reconstruction, post-processing, observer studies and treatment planning synergistically in a unified data-driven framework, positioning this project uniquely to eliminate metal artifacts and their complications in radiation therapy. This project will be pursued through the long-term academic-industrial partnership among Dr. Ge Wang at Ren- sselaer Polytechnic Institute (RPI), Dr. Bruno De Man at GE Research Center (GRC), and Dr. Harald Paganetti at Massachusetts General Hospital (MGH). While our teams will collaborate closely through the whole project, GRC has a history of CT research and translation, including direct raw data processing, and will focus on Aim 1. RPI is a pioneering group in tomographic reconstruction, especially deep-learning-based CT imaging, and will lead Aim 2. The MGH team is at the forefront of radiation therapy research and will be responsible for Aim 3. Upon completion of this project, we will have redefined the state of the art of CT MAR, largely eliminating CT metal artifacts and substantially improving radiation therapy planning and delivery accuracy. With the above-proposed networks for CT MAR, metal artifacts will have been basically eliminated, targeting residual errors <10 HU for photon and proton therapy planning, with the goal of reducing the clinical diametric error to ±3% and the proton range error due to metal artifacts to <2mm. Since our approach is software-based and open-source, the path for technology transfer and clinical translation is clearly defined, as well tested before.

IC Name
NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING
  • Activity
    R01
  • Administering IC
    EB
  • Application Type
    1
  • Direct Cost Amount
    2242677
  • Indirect Cost Amount
    351147
  • Total Cost
    2593824
  • Sub Project Total Cost
  • ARRA Funded
    False
  • CFDA Code
    286
  • Ed Inst. Type
    BIOMED ENGR/COL ENGR/ENGR STA
  • Funding ICs
    NIBIB:2593824\
  • Funding Mechanism
    Non-SBIR/STTR RPGs
  • Study Section
    ZRG1
  • Study Section Name
    Special Emphasis Panel
  • Organization Name
    RENSSELAER POLYTECHNIC INSTITUTE
  • Organization Department
    BIOMEDICAL ENGINEERING
  • Organization DUNS
    002430742
  • Organization City
    TROY
  • Organization State
    NY
  • Organization Country
    UNITED STATES
  • Organization Zip Code
    121803590
  • Organization District
    UNITED STATES